| Original language | English |
|---|---|
| Article number | awz082 |
| Pages (from-to) | 1168-1169 |
| Number of pages | 2 |
| Journal | Brain |
| Volume | 142 |
| Issue number | 5 |
| DOIs |
|
| State | Published - May 1 2019 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Brain, Vol. 142, No. 5, awz082, 01.05.2019, p. 1168-1169.
Research output: Contribution to journal › Comment/debate
TY - JOUR
T1 - The structure of amyloid-β dimers in Alzheimer's disease brain
T2 - A step forward for oligomers
AU - Bateman, Randall J.
AU - Mawuenyega, Kwasi G.
AU - Wildburger, Norelle C.
N1 - Funding Information: Funding for work in this paper is sup ported by the National Institutes of Health (R01NS095773, R56AG061900, R01NS065667) and an anonymous foundation. Funding Information: R.J.B. receives laboratory research funding from the National Institutes of Health (R01NS095773, R56AG061900, R01NS065667), Alzheimer’s Association, BrightFocus Foundation, Rainwater Foundation Tau Consortium, Association for Frontotemporal Degeneration, the Cure Alzheimer’s Fund, and the Tau SILK Consortium (AbbVie, Biogen, and Eli Lilly and Co.) Funding for clin ical trials include the National Institutes of Health (U01AG042791, R01AG046179, R01AG053267, U01AG059798, Alzheimer’s Association, Eli Lilly and Company, Roche/Genentech, Janssen, Avid Radiopharmaceuticals, GHR Foundation, and an anonymous organization. R.J.B. also receives research funding from the National Institutes of Health (UF1AG032438, R13AG055232, U19AG010483) and the DIAN-TU Pharma Consortium (AbbVie, Amgen, AstraZeneca, Biogen, Eisai, Elan, Eli Lilly and Co./ Avid Radiopharmaceuticals, Forum Pharmaceuticals, Roche/Genentech, Janssen, Mithridion, Novartis, Pfizer, and Sanofi). R.J.B. reports consulting fees/honoraria from AC Immune, Johnson & Johnson, Pfizer, Eisai, Roche, and Merck. R.J.B. reports equity ownership interest/advisory board income from C2N Diagnostics.
PY - 2019/5/1
Y1 - 2019/5/1
UR - https://www.scopus.com/pages/publications/85065418725
U2 - 10.1093/brain/awz082
DO - 10.1093/brain/awz082
M3 - Comment/debate
C2 - 31032843
AN - SCOPUS:85065418725
SN - 0006-8950
VL - 142
SP - 1168
EP - 1169
JO - Brain
JF - Brain
IS - 5
M1 - awz082
ER -